The aim of this proposal is to investigate the role of the transforming growth factor beta-related protein, DVR-6 (also known as Vgr-1 and Bone Morphogenetic Protein, BMP-6), in the growth and differentiation of the mouse embryo. Previous studies have shown that the DVR-6 gene is expressed in a variety of developing tissues, including the supranasal cells of the epidermis, the central and peripheral nervous system, cartilage, ovary, and pre-and postnatal kidney and lung. Based on known functions for other members of the TGFbeta superfamily, both in vertebrates and invertebrates, our hypothesis is that DVR-6 secreted by one cell type binds to receptors on a neighboring cell type and elicits changes in gene expression, proliferation and cell fate. A variety of approaches will be used to test this hypothesis for DVR-6 in the mouse. (1) DVR-6 protein will be misexpressed in transgenic mice, using heterologous gene regulatory regions. Initially, the bovine cytokeratin III gene promoter will be used to misexpress DVR-6 in the basal cells of the developing epidermis, and the mouse En-2 promoter will be used to misexpress the protein in the mid/hind brain region of the CNS. (2) Affinity purified antibodies against the C-terminal region of DVR-6 will be generated and used to study the biosynthesis, post-transnational modification, and extracellular location of the mature protein in vitro and in vivo. (3) DVR-6 will be purified from the conditioned medium of CHO cells and used to study the effect of the protein on a variety of neuronal cells in culture. In the long term the results will contribute to our understanding of the complex mechanisms regulating the growth, differentiation and morphogenesis of both embryonic tissue and adult tissues undergoing regeneration and repair. Disruption of these processes can lead to congenital malformations and cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA048799-07
Application #
5207545
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1996
Total Cost
Indirect Cost
Satterwhite, D J; White, R L; Aakre, M E et al. (2001) TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1. Pediatr Res 50:67-75
Norgaard, P; Law, B; Joseph, H et al. (1999) Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Clin Cancer Res 5:35-42
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Engel, M E; McDonnell, M A; Law, B K et al. (1999) Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274:37413-20
Gorska, A E; Joseph, H; Derynck, R et al. (1998) Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9:229-38
Alexandrow, M G; Moses, H L (1998) c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. J Cell Biochem 70:528-42
Zhao, G Q; Liaw, L; Hogan, B L (1998) Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 125:1103-12
Engel, M E; Datta, P K; Moses, H L (1998) RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J Biol Chem 273:9921-6
Datta, P K; Chytil, A; Gorska, A E et al. (1998) Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 273:34671-4
Serra, R; Johnson, M; Filvaroff, E H et al. (1997) Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-52

Showing the most recent 10 out of 62 publications